Sherbrooke Park Advisers’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-13,993	Closed	-$630K	–	1085
2024 Q3	$630K	Buy	13,993 +3,188	+30%	+$143K	0.14%	222
2024 Q2	$374K	Sell	10,805 -9,326	-46%	-$323K	0.07%	529
2024 Q1	$582K	Buy	+20,131	New	+$582K	0.11%	313